ReCOV: RT-PCR Database Analysis for COVID-19 Infections and Re-infection
Sponsor
University Hospital, Montpellier (Other)
Overall Status
Recruiting
CT.gov ID
NCT04653844
Collaborator
Laboratoire CERBA-MPL (Other), CNRS (MIVEGEC) (Other), Nîmes University Hospital (Other)
7,000,000
1
35.9
194755.5
Study Details
Study Description
Brief Summary
The SARS-Cov2 pandemic remains associated with many concerns. One of the them is the real frequency of likely re-infection and subsequently the level of protection conferred by the acquired immunity following primary-infection. We propose to analyze a large set of laboratory data produced since the early beginning of the SARS-Cov2 spread in the French population to identify recurrent infection events and, more generally, gain insight about infection kinetics.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
7000000 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
SARS-Cov2 (COVID-19) Infection and Reinfection Through the Analysis of a RT-PCR Results Database
Actual Study Start Date
:
Feb 1, 2020
Anticipated Primary Completion Date
:
Dec 31, 2022
Anticipated Study Completion Date
:
Jan 30, 2023
Outcome Measures
Primary Outcome Measures
- SARS-CoV-2 reinfection rate [1 day]
SARS-CoV-2 reinfection rate
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
- People with at least one positive SARS-Cov2 RT-PCR result with a known sampling date
Exclusion criteria:
- Patient refusing to participate in research
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Uh Montpellier | Montpellier | France | 34295 |
Sponsors and Collaborators
- University Hospital, Montpellier
- Laboratoire CERBA-MPL
- CNRS (MIVEGEC)
- Nîmes University Hospital
Investigators
- Study Director: Vincent Foulongne, PhD, UH MONTPELLIER
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04653844
Other Study ID Numbers:
- RECHMPL20_0640
First Posted:
Dec 4, 2020
Last Update Posted:
Jan 4, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms: